|
Olivia Goldhill is a science journalist who has been reporting on pharma, psychology and mental health for more than a decade. Currently a features editor atNew Scientistmagazine, her writing has also appeared in publications such as The New York Times, Guardian and Telegraph. Goldhill is a New America fellow and her work has been recognised as a 2022 British Journalism Awards finalist, 2021 EPPY finalist, and a 2020 Livingston Award finalist. She is based in London.
|